Skip to content
BidBenchmark

Contract award

RESEARCH TRIANGLE INSTITUTE

PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT
PIID
75N93023D00012
Award key
CONT_IDV_75N93023D00012_7529
Recipient UEI
JJHCMK4NT5N3
Source as of
Current award value
3
Obligated to date
$02
Potential with options
$30,000,0003
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Set-aside
No set-aside used
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition9 offers received
Period of performance
Sep 8, 2023Sep 7, 2030
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 8, 2023Initial award$0.00
P00001Aug 3, 2026M$0.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.272564bbd8f16

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N93023D00012 — RESEARCH TRIANGLE INSTITUTE · BidBenchmark